Medical devices
Butterfly Network, maker of a handheld ultrasound, also announced it had hired Joseph M. DeVivo as the company's new president and CEO.
At HIMSS23, panelists discussed why health systems need to consider the unique needs of their patient populations when implementing remote patient monitoring programs.
Opioid Halo provides escalating alerts to family and caregivers if it detects signs of opioid-induced respiratory depression.
The company targets to receive a similar clearance from the US FDA by yearend.
It has been approved for use in both clinical and home settings.
Also, PowerHealth has developed a new automated interface supporting aged care costing studies.
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.
The wearable device directly measures respiration to predict deterioration in COPD patients.
Also, Radlink is enhancing its chest x-ray reading capability using Lunit's AI technology.
The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.